Article Details
Retrieved on: 2024-10-07 17:08:35
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses how Starboard Value's investment in Pfizer, amid leadership changes and a strategic pivot from COVID-19 treatments to oncology, aligns with the biotech industry's focus on research and development, involving figures like Mikael Dolsten and Seagen.
Article found on: www.mmm-online.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here